ATE29879T1 - Zyklische dithioacetamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents
Zyklische dithioacetamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE29879T1 ATE29879T1 AT84401007T AT84401007T ATE29879T1 AT E29879 T1 ATE29879 T1 AT E29879T1 AT 84401007 T AT84401007 T AT 84401007T AT 84401007 T AT84401007 T AT 84401007T AT E29879 T1 ATE29879 T1 AT E29879T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- cyclic
- pharmaceutical compositions
- compositions containing
- atom
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 208000007056 sickle cell anemia Diseases 0.000 abstract 2
- WQTSYFWYWLTLIW-UHFFFAOYSA-N (acetyloxydisulfanyl) acetate Chemical compound CC(=O)OSSOC(C)=O WQTSYFWYWLTLIW-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 238000012239 gene modification Methods 0.000 abstract 1
- 230000005017 genetic modification Effects 0.000 abstract 1
- 235000013617 genetically modified food Nutrition 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 230000036244 malformation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 abstract 1
- 238000005891 transamination reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8308155A FR2546168B1 (fr) | 1983-05-17 | 1983-05-17 | Dithiodiacetamides cycliques, procede pour leur preparation et compositions pharmaceutiques en contenant |
| EP84401007A EP0126013B1 (de) | 1983-05-17 | 1984-05-17 | Zyklische Dithioacetamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE29879T1 true ATE29879T1 (de) | 1987-10-15 |
Family
ID=9288923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84401007T ATE29879T1 (de) | 1983-05-17 | 1984-05-17 | Zyklische dithioacetamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4642306A (de) |
| EP (1) | EP0126013B1 (de) |
| JP (1) | JPS6056974A (de) |
| KR (1) | KR840009099A (de) |
| AT (1) | ATE29879T1 (de) |
| CA (1) | CA1224462A (de) |
| DE (1) | DE3466390D1 (de) |
| FR (1) | FR2546168B1 (de) |
| IL (1) | IL71840A (de) |
| OA (1) | OA07773A (de) |
| ZA (1) | ZA843694B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19618445A1 (de) * | 1996-05-08 | 1997-11-13 | Wella Ag | Mittel und Verfahren zur dauerhaften Haarverformung auf Basis von Mercaptoacetamiden sowie Verfahren zu deren Herstellung |
| DE19732079C1 (de) * | 1997-07-25 | 1999-02-04 | Wella Ag | Gesättigte, alkylsubstituierte N-Mercaptoacetyl-Heterocyclen, Mittel und Verfahren zur dauerhaften Haarverformung auf deren Basis |
| CA3043222A1 (en) * | 2016-11-28 | 2018-05-31 | Dana-Farber Cancer Institute, Inc. | Reagents and methods for analysis of proteins and metabolites targeted by covalent probes |
-
1983
- 1983-05-17 FR FR8308155A patent/FR2546168B1/fr not_active Expired
-
1984
- 1984-05-15 KR KR1019840002634A patent/KR840009099A/ko not_active Abandoned
- 1984-05-15 IL IL71840A patent/IL71840A/xx not_active IP Right Cessation
- 1984-05-16 CA CA000454452A patent/CA1224462A/en not_active Expired
- 1984-05-16 ZA ZA843694A patent/ZA843694B/xx unknown
- 1984-05-17 US US06/611,516 patent/US4642306A/en not_active Expired - Fee Related
- 1984-05-17 EP EP84401007A patent/EP0126013B1/de not_active Expired
- 1984-05-17 OA OA58300A patent/OA07773A/xx unknown
- 1984-05-17 AT AT84401007T patent/ATE29879T1/de not_active IP Right Cessation
- 1984-05-17 JP JP59099644A patent/JPS6056974A/ja active Pending
- 1984-05-17 DE DE8484401007T patent/DE3466390D1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2546168A1 (fr) | 1984-11-23 |
| EP0126013B1 (de) | 1987-09-23 |
| OA07773A (fr) | 1985-08-30 |
| KR840009099A (ko) | 1984-12-24 |
| JPS6056974A (ja) | 1985-04-02 |
| FR2546168B1 (fr) | 1985-08-30 |
| CA1224462A (en) | 1987-07-21 |
| IL71840A0 (en) | 1984-09-30 |
| DE3466390D1 (en) | 1987-10-29 |
| ZA843694B (en) | 1984-12-24 |
| US4642306A (en) | 1987-02-10 |
| EP0126013A1 (de) | 1984-11-21 |
| IL71840A (en) | 1987-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE79376T1 (de) | Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| PL268455A1 (en) | The method of manufacture of new derivatives of benzimidazole | |
| RU99105211A (ru) | Арилалканоилпиридазины | |
| ATE40368T1 (de) | Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE19878T1 (de) | Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE17728T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE69807T1 (de) | Phenoxyessigsaeure-verbindungen, ihre herstellung, pharmazeutische zusammensetzungen und deren verwendung. | |
| ATE38988T1 (de) | Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| KR890009845A (ko) | 아릴옥시페닐 프로필아민, 이의 제조방법 및 용도 | |
| ATE6645T1 (de) | Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| ATE18549T1 (de) | 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
| DE3850603D1 (de) | Arylaralkylether, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung. | |
| ATE29879T1 (de) | Zyklische dithioacetamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE33022T1 (de) | S-(carbamoyl-phenylselenyl)-derivate von mercaptanen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| ATE107298T1 (de) | 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE69120699D1 (de) | N-Monosubstituierte Cyclopentenylamine, ein Verfahren zu ihrer Herstellung, und ihre Verwendung als Medikament | |
| ATE53209T1 (de) | Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. | |
| ATE38982T1 (de) | Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel. | |
| EP0173377A3 (de) | Pyrimidinonverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
| DE3660764D1 (en) | Triazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| DE69214728D1 (de) | Dithian substituierte Retinoide, ihre Verwendung, Verfahren zu ihrer Herstellung, diese enthaltende kosmetische und pharmazeutische Zusammensetzungen und ihre therapeutische Verwendung | |
| HUT37593A (en) | Process for preparing pharmaceutical compositions of antianginose effect | |
| DE69013980D1 (de) | Tetrahydropyranylderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische oder tiermedizinische Zusammensetzungen. | |
| ATE60333T1 (de) | D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |